Use of hyperbaric oxygen therapy of purpura fulminans in an extremely low birth weight preterm: A case report.

J Neonatal Perinatal Med

Department of Neonatology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey.

Published: July 2023

Purpura fulminans (PF) is a rare and fatal complication of septic shock or diffuse intravascular coagulation (DIC) resulting in skin and soft tissue necrosis. PF can be caused by congenital or acquired protein C (PC) or protein S (PS) deficiency. The most common cause of PF in a neonate is sepsis. In our extremely low birth weight preterm case, due to PF that started in the right-hand fingers, examination was made and protein S deficiency was detected as well as MTHFR (A1298C) and Factor V Leiden (R506Q) homozygous mutations. While being unresponsive to fresh frozen plasma (FFP) and unfractionated heparin (UFH) therapy, we want to highlight the curative treatment with hyperbaric oxygen (HBOT), which has not previously been used in extremely low birth weight preterm infants for this purpose.

Download full-text PDF

Source
http://dx.doi.org/10.3233/NPM-200428DOI Listing

Publication Analysis

Top Keywords

extremely low
12
low birth
12
birth weight
12
weight preterm
12
hyperbaric oxygen
8
purpura fulminans
8
preterm case
8
protein deficiency
8
oxygen therapy
4
therapy purpura
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!